Pharma-Bio Serv, Inc. (PBSV) stock: key figures, P/E, revenue and dividend

Industrials · United States · ISIN US71711N1000

Price
0.50 USD
Market cap
11.48 m USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
15.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–

Pharma-Bio Serv, Inc. financials

Fiscal year2025
Revenue9.00 m USD
Gross profit2.91 m USD
Operating income-637,662.00 USD
EBIT-131,786.00 USD
Net income-100,463.00 USD
Diluted EPS – continuing operations-0.00 USD

Full history since 2007, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Pharma-Bio Serv, Inc.

Pharma-Bio Serv, Inc. operates as a regulatory affair, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company offers a broad range of technical compliance consulting services, including regulatory affairs, quality assurance, compliance, technology transfer, validation, engineering, project management, and process support. It serves pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. The company was founded in 1993 and is headquartered in Dorado, Puerto Rico.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.